Answers are grounded in this paper and cite their sources.
Background Mycoplasma genitalium (MG) is an emerging sexually transmitted pathogen, particularly among female sex workers (FSWs), where infection and antimicrobial resistance patterns remain underexplored in India. Aim To determine the prevalence and resistance pattern of MG among FSWs. Methods 230 FSWs were recruited from December 2021 to December 2024. Sociodemographic data and clinical history were recorded. Multiple specimen types were collected for MG detection using real-time PCR. MG positive isolates were sequenced to identify resistance-associated mutations. Additionally, screening for Neisseria gonorrhoeae (NG) , Chlamydia trachomatis (CT), Ureaplasma urealyticum (UU) and Mycoplasma hominis (MH) was also performed. HIV and syphilis status were collected from previous records. The findings were compared with a meta-analysis of 26 studies (including current study) conducted globally, encompassing 11,159 FSWs. Results A total of 230 participants were enrolled in the study. The mean participant age was 30.3 ± 8.7 years. MG infection was detected in 12/230 participants (5.21%), predominantly in women under 30 years of age. Among the 12 MG-positive participants, endocervical swabs yielded the highest positivity (80%). MG mono-infection was observed in 5 (41.7%) cases, while 7 (58.3%) had co-infections involving MH and/or UU. The pooled global prevalence of MG among FSWs was 12.28% (95% CI: 9.54%-15.02%) with high between-study heterogeneity (I 2 = 96.01%). Among the MG-positive isolates, two harboured macrolide resistance-associated mutations (MRMs). Of these, one isolate also carried a fluoroquinolone resistance -associated mutation. Limitations The limitations included a lack of data regarding condom use, prior antimicrobial usage and follow-up sampling. Conclusion This is the first Indian study estimating MG prevalence by real-time PCR and sequencing, highlighting a relatively lower prevalence compared to global data, but it demonstrates the presence of clinically relevant drug resistance. These findings emphasise the significance of regional surveillance to guide diagnosis and antimicrobial stewardship in key populations.
No takes yet. Share an insight, caveat, or question.
Tsephel et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: